SCHEMBL5004431

SCHEMBL5004431

O=C(O)C1CCCN(C2CC3(CCCCC3)C2)C1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.54
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ HRH1 P35367 4/20 0.45
▸ HTR2A P28223 3/20 0.45
▸ HTR2C P28335 2/20 0.45
▸ HTR2B P41595 2/20 0.45
▸ GRM5 P41594 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ HRH3 Q9Y5N1 3/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ KDM2B Q8NHM5 2/20 0.35
▸ POLB P06746 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ HSD11B1 P28845 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5009495 0.98 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2HRH1HTR2AHTR2C
SCHEMBL21047551 0.93 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2HRH1HTR2AHTR2C
SCHEMBL21047253 0.77 BCHE (0.44) ALDH1A1SMN1; SMN2HRH1HTR2AHTR2C
SCHEMBL10859973 0.77 ALDH1A1 (0.71) ALDH1A1SMN1; SMN2HRH1HTR2AHTR2C
SCHEMBL21047419 0.76 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2HRH1HTR2AHTR2C
SCHEMBL21047409 0.75 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2HRH1HTR2AHTR2C
SCHEMBL21047431 0.74 ALDH1A1 (0.62) ALDH1A1SMN1; SMN2HRH1HTR2AHTR2C
Hydrochloric Acid SCHEMBL3371779 0.74 ALDH1A1 (0.67) ALDH1A1SMN1; SMN2MEN1KMT2AKDM2B
SCHEMBL27097525 0.72 OPRL1 (0.33) HRH3
SCHEMBL22160003 0.72 CYP2C19 (0.67) ALDH1A1SMN1; SMN2GRM5KDM4ECYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080280879-A1 SUBSTITUTED HETEROCYCLIC DERIVATIVES AND THEIR PHARMACEUTICAL USE AND COMPOSITIONS PFIZER INC 2008-11-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080280879-A1 SUBSTITUTED HETEROCYCLIC DERIVATIVES AND THEIR PHARMACEUTICAL USE AND COMPOSITIONS XDH, CYP2D6, F12 ALDH1A1 3777/4885SMN1; SMN2 4085/4885HRH1 133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback